Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

Good points, Meishar, and well said. What's going on here is simple "share price bias." People get frustrated with the pps and they start looking for scapegoats. If the share price was 20 nobody would be complaining about management. As if the management team of a clinical-stage biotech has even indirect control over the share price. The small biotech sector is easily the most manipulated segment of the entire stock market. No real numbers to crunch to determine value, so the manipulators have their way with it. Not to mention the entire sector being severely beaten down in the last 12 months.